IAC Express 2009 |
Issue number 784: March 9, 2009 |
|
Please click here to subscribe to IAC Express
as well as other FREE IAC periodicals. |
|
Contents
of this Issue
Select a title to jump to the article. |
- IAC's
laminated versions of the 2009 child/teen and adult immunization schedules
offer significant advantages over paper versions. Place your order today
and use them throughout 2009!
- IAC's
redesigned VIS web section is your source for easily accessible VISs in
many languages and formats
- Influenza
complications have killed 22 U.S. children during the current influenza
season. It is vital to continue vaccinating through the spring months
- IAC's
Video of the Week is a doo-wop ditty promoting influenza vaccination for
healthcare workers
- NCIRD
provides updated information on vaccine supply and shortages
- Spring
issue of Stanford Medicine features a special report, "Hot Shots: Vaccines
under the gun"
- Archive
of the webcast "Vaccines: Wading through the Confusion" now available from
California
- What to
Expect Foundation video answers parents' pressing questions about
immunization
- New VIS
translation: Interim multi-vaccine VIS now available in Korean
- NCIRD's
new online tool gives users lots of useful information at the click of a
mouse
- MMWR
publishes article on hepatitis C virus transmission at a New York
outpatient hemodialysis unit during 2001-08
-
Coalition University's second and third semesters planned for March 18-19
and May 13 in Baltimore; related Points Across VI conference to be held
May 14
- MMWR
publishes article on progress Afghanistan and Pakistan made toward polio
eradication in 2008
|
|
Abbreviations |
|
AAFP, American Academy of Family Physicians; AAP,
American Academy of Pediatrics; ACIP, Advisory Committee on Immunization
Practices; AMA, American Medical Association; CDC, Centers for Disease
Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD,
National Center for Immunization and Respiratory Diseases; NIVS, National
Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD,
vaccine-preventable disease; WHO, World Health Organization. |
|
Issue 784: March 9, 2009 |
|
|
1. |
IAC's laminated versions of the 2009 child/teen and adult immunization
schedules offer significant advantages over paper versions. Place your order
today and use them throughout 2009!
IAC's 2009 laminated immunization schedules are a
must for every exam room at your practice site. We offer the laminated
schedules for two age groups. The child/teen immunization schedule is for
people ages 0 through 18 years; the adult schedule is for those older than
18. Though both are adapted from the immunization schedules that were posted
on the CDC website in January, the laminated schedules offer these advantages
over downloadable paper versions:
- Coated in thick plastic, the laminated
schedules are washable and will hold up to a year's worth of use as
teaching tools that give providers, patients, and parents authoritative
information about the vaccines recommended for various age groups. You can
also use them as a handy reference to consult at a moment's notice.
- For the second year in a row, IAC has
added a significant feature to the two laminated schedules. Each includes
a guide to contraindications and precautions for the pertinent age group
(i.e., the child/teen schedule has a guide to contraindications and
precautions for child/teen vaccines, and the adult schedule has a guide
for adult vaccines). Healthcare professionals will find these guides
extremely valuable in making an on-the-spot determination about
vaccinating any patient they see in their practice.
The durable laminated schedules come complete
with essential footnotes and are printed in color for easy reading. Each
schedule has six pages (i.e., three double-sided pages), and when folded,
measures 8.5" x 11".
To learn more about the schedules, to view images of each, or to order online
or download an order form, visit
www.immunize.org/shop
Prices start at $10 each for 1-4 copies and drop to $6.50 each for 5-19
copies. Discount pricing is available for 20 or more copies. For quotes on
customizing or placing orders in excess of 999 schedules, call (651) 647-9009
or email admininfo@immunize.org
Back to top |
|
|
2. |
IAC's redesigned VIS web section is your source for easily accessible VISs in
many languages and formats
Making Vaccine Information Statements (VISs)
available in more than 35 languages is a hallmark of IAC's website. The VIS
home page is the website's most frequently visited section, receiving
thousands of visits each day. IAC recently fine-tuned the look and navigation
of the VIS web section, making it simple for visitors to find the most recent
issue dates of VISs at a glance and to access up-to-date VISs easily.
Need to check for current VIS dates? IAC maintains a quick-reference chart of
dates on the VIS home page. Check the dates on your VISs against the dates on
the chart. If your supply of VISs contains any out-of-date ones, you can
choose to search for VISs sorted alphabetically, as well as by vaccine name
and language. Note: All VISs on IAC's site are in ready-to-print (PDF)
format. You will need Adobe Reader to view them.
To view the VIS home page, go to:
http://www.immunize.org/vis
To view the "VISs Alphabetical" web page, go to:
http://www.immunize.org/vis/?f=7
To view the "VISs by Vaccine" index page, go to:
http://www.immunize.org/vis/?f=8
To view the "VISs by Language" index page, go to:
http://www.immunize.org/vis/?f=9
Look for the new navigation column on the left side of the VIS home page. It
provides quick links to more VIS web subsections, such as "How to Use VISs,"
"Other VIS Sources," "VISs in Alternative Formats," and "Michigan Versions of
VISs." You will also find links to "More IAC Materials."
Are you interested in providing IAC with any new or updated translations of
VISs? Read the letter of instruction at http://www.immunize.org/translating/trans_letter.pdf
Then contact admininfo@immunize.org
For information about the use of VISs, and for VISs in more than 35
languages, visit IAC's VIS web section at
http://www.immunize.org/vis
Back to top |
|
|
3. |
Influenza complications have killed 22 U.S. children during the current
influenza season. It is vital to continue vaccinating through the spring
months
U.S. Influenza activity is really on the move. In
the week of
February 22-28, CDC received reports of five more U.S. children
killed by complications from influenza; the total of reported
pediatric influenza deaths this influenza season now stands at
22. Thirty-one states have reported widespread influenza
activity, up from 27 the previous week.
Yearly vaccination is the first and most important step in
protecting against influenza and its complications. It is
important to continue vaccinating into the spring months. The
supply of influenza vaccine is robust; if you run out of vaccine
in your work setting, please place another order.
For abundant information about influenza vaccination, visit the
following two websites often. They are continually updated with
the latest resources:
The National Influenza Vaccine Summit website at
http://www.preventinfluenza.org
CDC's Seasonal Flu web section at http://www.cdc.gov/flu
Back to top |
|
|
4. |
IAC's Video of the Week is a doo-wop ditty promoting influenza vaccination
for healthcare workers
Using song and lyrics to raise awareness of the
importance of
influenza vaccination for its employees, the Hospital of the
University of Pennsylvania created a five-minute video, "Baby,
Be Wise--Immunize." It features scores of employees lip-synching
to a doo-wop beat.
The video will be available on the home page of IAC's website
through March 15. To access it, go to: http://www.immunize.org
and click on the image under the words Video of the Week, which
you'll find toward the top of the page. It may take a few
moments for the video to begin playing; please be patient!
Remember to bookmark IAC's home page to view a new video every
Monday. While you're at our home page, we encourage you to
browse around--you're sure to find resources and information
that will enhance your practice's immunization delivery.
To view IAC's video collection, go to:
http://www.vaccineinformation.org/video
Back to top |
|
|
5. |
NCIRD provides updated information on vaccine supply and shortages
On March 2, NCIRD updated its information on the
supply status
of vaccines recommended in the U.S. childhood and adolescent
immunization schedule. The updated information is reprinted
below.
PEDIATRIC HEPATITIS B. In February 2009, both Merck and GSK
experienced an inability to fill orders for pediatric Hepatitis
B vaccine, resulting in backorders. CDC has released doses from
its monovalent pediatric Hepatitis B vaccine stockpiles to each
manufacturer to support private and public sector vaccine usage
through March. Merck expects supplies of pediatric Recombivax HB
to be limited during the remainder of 2009 and does not expect
to return to a full supply until some time in 2010. GSK expects
to be able to meet the U.S. market demand for monovalent
Hepatitis B vaccine through the end of May with its pediatric
Hepatitis B vaccine (Pediatric Engerix-B), and is working
closely with CDC to determine how much additional monovalent
Hepatitis B product can be supplied to the U.S. market during
the second half of 2009.
ADULT HEPATITIS B: In December 2008, Merck communicated with CDC
that it expected to deplete available adult and dialysis
formulations of their hepatitis B vaccine, Recombivax HB, in the
first quarter of 2009. Once depleted, these formulations will be
unavailable for the remainder of 2009. Supply of GSK's Adult
hepatitis B vaccine (Adult Engerix-B) and Adult hepatitis
A/hepatitis B combination vaccine (Twinrix) is sufficient to
meet demand for routine adult usage of this vaccine as well as
[for] CDC's ongoing High Risk Adult Hepatitis B Initiative.
HIB: Merck is working to restore market availability of Hib-containing vaccines, PedvaxHIB and Comvax, but the availability
of these vaccines may be subject to a further delay, with
Merck's current estimate of availability being mid-to-late 2009.
In response to the shortage, CDC and AAP recommend deferral of
the booster dose at 12-through-15 months of age except in high-risk groups. Sanofi pasteur currently is providing sufficient
Hib vaccine (ActHIB and Pentacel) to cover the 3-dose series
through mid 2009, and has developed a supply plan to support
reinstatement of the booster dose some time in mid 2009, using a
combination of their Hib-containing products. CDC will work
closely with sanofi pasteur to determine available supply and
options for catch up.
MONOVALENT MEASLES, MUMPS, RUBELLA: In December 2008, Merck
communicated with CDC that it was not producing or taking orders
for the monovalent vaccines ATTENUVAX (measles vaccine),
MUMPSVAX (mumps vaccine), and MERUVAX (rubella vaccine). Merck
has not yet made a decision about the future availability of
these three monovalent vaccines.
VARICELLA AND ZOSTER: There is adequate supply of Varivax
(varicella vaccine) to fully implement the recommended 2-dose
immunization schedule, including catch-up, for all age groups.
ProQuad (MMRV) will not be available in 2009. Zostavax (zoster
vaccine) is available for ordering; however, the manufacturer is
experiencing shipping delays. Merck anticipates a return to
normal shipping times for Zostavax in mid-2009. Merck vaccine
supply status, including specific shipping status information
for zoster vaccine, is updated weekly and may be found at
http://www.merck.com/e-business/reports/MVC_Supply_Status.pdf
PEDIATRIC AND ADULT HEPATITIS A. Merck & Co previously had
experienced production delays that resulted in temporarily not
accepting orders for Pediatric and Adult hepatitis A vaccines
(Pediatric & Adult VAQTA). As of December 1, 2008, Merck's
Pediatric/Adolescent formulation of hepatitis A vaccine, VAQTA,
is available for ordering. Merck estimates that the Adult
formulation of VAQTA may be available in the second quarter
2009. GSK production and supply of their Pediatric and Adult
hepatitis A vaccine (Pediatric & Adult Havrix) and their Adult
hepatitis A/hepatitis B combination vaccine (Twinrix) are in
adequate supply to meet demand.
NCIRD updates vaccine supply information as needed to provide
public information on vaccine shortages and/or delays.
To access vaccine supply and shortage information, go to:
http://www.cdc.gov/vaccines/vac-gen/shortages/default.htm
To receive email notification of updated information, click on
the URL above; then click on the link near the top of the page
titled Get Email Updates (it's next to an image of a mailbox).
Back to top |
|
|
6. |
Spring issue of Stanford Medicine features a special report, "Hot Shots:
Vaccines under the gun"
The journal Stanford Medicine has devoted the
lion share of its
spring 2009 issue to a special report on vaccines and
immunization. Titled "Hot Shots: Vaccines under the gun," the
report comprises articles that examine vaccines and vaccination
from many angles. The table of contents follows:
-
A letter from former First Lady Rosalynn Carter, president and
co-founder of Every Child By Two
-
The demonization of immunization: Shots get the once over
-
What is a vaccine? Immunization demystified
-
Asking how: Vaccine side effects probed
-
When science gets hijacked: NBC News chief medical editor
tells why she broke her silence
-
Insourced to India: A vaccine for a scourge of the developing
world
-
Peet's passion: The medical education of Amanda Peet
-
Field yields: Can genetically-engineered plants provide
vaccines?
-
Shoot it, don't smoke it: An injectable tobacco-grown vaccine
-
Golden needles: Vaccines for seniors
-
Grow up: What to do when immunity wanes
In addition, the Departments section of the spring issue
includes another vaccine-related article, "Backstory--A vaccine
against vampires: The genetics of TB hold the key."
To access Stanford Medicine's spring issue, go to:
http://stanmed.stanford.edu/2009spring
Back to top |
|
|
7. |
Archive of the webcast "Vaccines: Wading through the Confusion" now available
from California
Originally held on February 19, the webcast
"Vaccines: Wading
through the Confusion" is now available on the website of the
California Department of Public Health. The 1.5-hour video
features a panel of medical, scientific, public health, and
communication professionals discussing parents' questions and
fears about vaccines. It also includes parents whose lives have
been touched by vaccine-preventable diseases or by autism.
To access the video, go to:
http://www.brochure2blog.org/publichealthcafe
Note: The video begins with about five minutes of recorded
music; the panel discussion follows.
Back to top |
|
|
8. |
What
to Expect Foundation video answers parents' pressing questions about
immunization
The website of the What to Expect Foundation
recently added a
14-minute video to its web section on childhood immunization.
The video features Heidi Murkoff, the author of the popular What
to Expect When You're Expecting prenatal and parenting books,
and Dr. Jay M. Lieberman, pediatrician and professor of
pediatrics, University of California School of Medicine, Irvine.
The video, which can be viewed in short segments, answers
questions about the number, safety, and timing of childhood
vaccinations. To access the video, go to:
http://www.whattoexpect.com/child-vaccinations
An array of downloadable immunization information is also
available from the link above, including the "What to Expect
Guide to Immunizations," available in English and Spanish.
The What to Expect Foundation is the nonprofit arm of the What
to Expect When You're Expecting book series.
Back to top |
|
|
9. |
New
VIS translation: Interim multi-vaccine VIS now available in Korean
Dated 9/18/08, the most current version of the
interim multi-vaccine VIS is available for the first time in Korean. IAC
gratefully acknowledges the Minnesota Department of Health for
the translation.
To access the Korean version of the interim multi-vaccine VIS,
go to: http://www.immunize.org/vis/ko_multi.pdf
To access the English version of the interim multi-vaccine VIS,
go to: http://www.immunize.org/vis/vis_multi1.pdf
For information about the use of VISs, and for VISs in more than
35 languages, visit IAC's VIS web section at
http://www.immunize.org/vis
For general information about VISs from CDC's website go to:
http://www.cdc.gov/vaccines/pubs/vis
Back to top |
|
|
10. |
NCIRD's new online tool gives users lots of useful information at the click
of a mouse
NCIRD recently added a new online tool to its
website--a
sortable table of basic information about vaccines licensed for
use in the U.S. It allows users to access information by vaccine
name, abbreviation, trade name, and manufacturer. As an example,
a user who was interested in finding out about Kinrix would
click on the "trade name" column heading to get a listing of
vaccines sorted alphabetically by trade name. From there, the
user would learn that Kinrix is a DTaP-IPV inactivated
combination vaccine manufactured by GlaxoSmithKline and licensed
for intramuscular administration to children ages 4-6 years as
the fifth dose of DTaP and the fourth dose of IPV. Pretty slick!
To access the table, go to:
http://www.cdc.gov/vaccines/about/terms/USVaccines.html
NOTE: The abbreviations given in the table are the standardized
vaccine abbreviations agreed upon by various groups and
individuals within CDC and beyond. They are intended to provide
a uniform approach to vaccine references used in ACIP
immunization recommendations, MMWR articles, NCIRD's Pink Book,
AAP's Red Book, and other publications. For more information, go
to: http://www.cdc.gov/vaccines/recs/acip/vac-abbrev.htm
Back to top |
|
|
11. |
MMWR publishes article on hepatitis C virus transmission at a New York
outpatient hemodialysis unit during 2001-08
CDC published "Hepatitis C Virus Transmission at
an Outpatient
Hemodialysis Unit--New York, 2001-2008" in the March 6 issue of
MMWR. A summary made available to the press is reprinted below
in its entirety.
Hepatitis C virus and other infections can spread in healthcare
settings when proper infection control procedures are not
followed. All patients treated in hemodialysis units should be
screened for hepatitis C virus (HCV) infection. CDC recommends
routine screening in hemodialysis settings to quickly identify
and halt potential transmission. It is critical that all
healthcare providers understand and follow correct infection
control practices to ensure the safety of their patients and
prevent transmission of viral hepatitis in healthcare
facilities. Preventing these outbreaks is the responsibility of
every healthcare worker and represents basic patient safety.
Provider education and infection control training is critical.
Hemodialysis patients should ask their provider if they have
been tested for hepatitis C virus. Patients needing healthcare
should continue to seek access to it and should not stop
receiving care due to perceived risk. Patients should discuss
any concerns with their provider. Due to basic breaches in
infection control, several viral hepatitis outbreaks have
occurred in recent years in healthcare settings. This
investigation documents four cases of patient-to-patient
transmission of HCV infection and identified five additional
patients who might have acquired HCV infection while receiving
treatment at a common outpatient hemodialysis center. Multiple
potential mechanisms of HCV transmission were identified,
including contaminated healthcare worker hands and treatment
surfaces. This outbreak highlights the need for hemodialysis
units to adhere to CDC recommendations for infection control and
comprehensive HCV surveillance, including routine anti-HCV
screening and prompt reporting of HCV infections to the local
health department.
To access a web-text (HTML) version of the complete article, go
to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5808a2.htm
To access a ready-to-print (PDF) version of this issue of MMWR,
go to: http://www.cdc.gov/mmwr/PDF/wk/mm5808.pdf
To receive a FREE electronic subscription to MMWR (which
includes new ACIP recommendations), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html
Back to top |
|
|
12. |
Coalition University's second and third semesters planned for March 18-19 and
May 13 in Baltimore; related Points Across VI conference to be held May 14
The second and third semesters of the Coalition
University's
three-part training series will be held in Baltimore on March
18-19 and May 13, respectively. Intended for health promotion
professionals, the related Points Across VI conference is
scheduled for May 14, also in Baltimore. Information on the
Coalition University's second and third semesters and Points
Across VI follow.
COALITION UNIVERSITY'S SECOND AND THIRD SEMESTERS
The Coalition University series is designed to provide the
multi-disciplinary skill set necessary for creating,
maintaining, and participating in successful coalitions.
The second semester will focus on conflict management,
fundraising, strategic planning (part I), board development, and
cultural competency. The third semester will cover volunteer
management, media relations, strategic planning (part II),
advocacy, and program evaluation.
To download the Coalition University class schedule and
registration information in ready-to-print (PDF) format, go to:
http://www.edcp.org/pdf/Coalition_University_Reg.pdf Note:
Limited space is still available for the second semester.
POINTS ACROSS VI
This year's Points Across conference is titled Back to the
Basics. It will present information on professional development
and self-care for health promotion professionals. To download
information about the conference, including registration
information, go to:
http://www.edcp.org/pdf/2009_Points_Across_VI_Brochure.pdf
For additional information on either the Coalition University or
Points Across VI, email info@immunizemaryland.org or call
(410) 902-4677.
Back to top |
|
|
13. |
MMWR publishes article on progress Afghanistan and Pakistan made toward polio
eradication in 2008
CDC published "Progress Toward Poliomyelitis
Eradication--Afghanistan and Pakistan, 2008" in the March 6 issue of MMWR. A
summary made available to the press is reprinted below in its
entirety.
In addition to continued support from the international polio
eradication partnership, interruption of wild poliovirus (WPV)
transmission in Afghanistan and Pakistan will require overcoming
one of the most important remaining challenges in polio
eradication globally: the barriers to access and vaccination of
children in large, remote, and security-compromised areas.
Efforts to engage political and tribal leaders will need to be
enhanced to secure access and safe passage of vaccination teams
to these areas. In the interim, critical improvements are needed
in the quality of immunization campaigns and delivery of routine
immunization in both countries. During 2008, Afghanistan and Pakistan continued to conduct coordinated immunization campaigns
against WPV. In total, 149 WPV cases (31 in Afghanistan and 118
in Pakistan) were confirmed in 2008, compared with 49 cases (17
in Afghanistan and 32 in Pakistan) in 2007. Security problems in
areas along the common border limited access by vaccination
teams to large numbers of children in the two countries. In
Pakistan, continued managerial and operational problems impeded
full implementation of immunization campaigns and adversely
affected vaccination coverage. Further progress toward
interruption of WPV transmission in Afghanistan and Pakistan
will require continued measures to overcome access problems in
conflict-affected areas of both countries and improvements in
the quality of immunization activities and delivery of routine
immunization services in Pakistan.
To access a web-text (HTML) version of the complete article, go
to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5808a4.htm
To access a ready-to-print (PDF) version of this issue of MMWR,
go to: http://www.cdc.gov/mmwr/PDF/wk/mm5808.pdf
Back to top |
|
|
|